CN102603627A - 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物及其制备方法 - Google Patents
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物及其制备方法 Download PDFInfo
- Publication number
- CN102603627A CN102603627A CN2011101434964A CN201110143496A CN102603627A CN 102603627 A CN102603627 A CN 102603627A CN 2011101434964 A CN2011101434964 A CN 2011101434964A CN 201110143496 A CN201110143496 A CN 201110143496A CN 102603627 A CN102603627 A CN 102603627A
- Authority
- CN
- China
- Prior art keywords
- verivate
- amino acid
- compound
- acid according
- meant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WLJMCRWYIXLKQL-UHFFFAOYSA-N CCOC(c1ccc(cc(cc2)O)c2c1)=O Chemical compound CCOC(c1ccc(cc(cc2)O)c2c1)=O WLJMCRWYIXLKQL-UHFFFAOYSA-N 0.000 description 1
- KAUQJMHLAFIZDU-UHFFFAOYSA-N OC(c(cc1)cc(cc2)c1cc2O)=O Chemical compound OC(c(cc1)cc(cc2)c1cc2O)=O KAUQJMHLAFIZDU-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110143496 CN102603627B (zh) | 2011-05-31 | 2011-05-31 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110143496 CN102603627B (zh) | 2011-05-31 | 2011-05-31 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102603627A true CN102603627A (zh) | 2012-07-25 |
CN102603627B CN102603627B (zh) | 2013-02-06 |
Family
ID=46521468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110143496 Expired - Fee Related CN102603627B (zh) | 2011-05-31 | 2011-05-31 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102603627B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103288728A (zh) * | 2013-05-17 | 2013-09-11 | 华侨大学 | 一种萘甲酰胺衍生物、其制备方法以及应用 |
CN103351336A (zh) * | 2013-06-28 | 2013-10-16 | 华侨大学 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘甲酰胺衍生物及其制备方法 |
CN103896836A (zh) * | 2014-03-20 | 2014-07-02 | 华侨大学 | N-苯基-6-[(7-氯喹啉-4-氧基)酚醚]-2-萘甲酰胺及其制备方法 |
CN103923004A (zh) * | 2014-04-04 | 2014-07-16 | 华侨大学 | 一种萘甲酰胺衍生物及其制备和应用 |
CN104447534A (zh) * | 2014-12-04 | 2015-03-25 | 厦门大学 | 6-[(7-氯喹啉-4-氧基)酚醚]-2-萘甲酰胺类衍生物及其制备方法和用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005021553A1 (en) * | 2003-08-29 | 2005-03-10 | Pfizer Inc. | Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
WO2005070891A2 (en) * | 2004-01-23 | 2005-08-04 | Amgen Inc | Compounds and methods of use |
US20100298358A1 (en) * | 2009-05-22 | 2010-11-25 | Shenzhen Chipscreen Biosciences Ltd. | Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors |
CN101906076A (zh) * | 2009-06-04 | 2010-12-08 | 深圳微芯生物科技有限责任公司 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用 |
CN102260210A (zh) * | 2011-05-30 | 2011-11-30 | 王立强 | 蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物的制备方法 |
-
2011
- 2011-05-31 CN CN 201110143496 patent/CN102603627B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005021553A1 (en) * | 2003-08-29 | 2005-03-10 | Pfizer Inc. | Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
WO2005070891A2 (en) * | 2004-01-23 | 2005-08-04 | Amgen Inc | Compounds and methods of use |
US20100298358A1 (en) * | 2009-05-22 | 2010-11-25 | Shenzhen Chipscreen Biosciences Ltd. | Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors |
CN101906076A (zh) * | 2009-06-04 | 2010-12-08 | 深圳微芯生物科技有限责任公司 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用 |
CN102260210A (zh) * | 2011-05-30 | 2011-11-30 | 王立强 | 蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物的制备方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103288728A (zh) * | 2013-05-17 | 2013-09-11 | 华侨大学 | 一种萘甲酰胺衍生物、其制备方法以及应用 |
CN103351336A (zh) * | 2013-06-28 | 2013-10-16 | 华侨大学 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘甲酰胺衍生物及其制备方法 |
CN103896836A (zh) * | 2014-03-20 | 2014-07-02 | 华侨大学 | N-苯基-6-[(7-氯喹啉-4-氧基)酚醚]-2-萘甲酰胺及其制备方法 |
CN103923004A (zh) * | 2014-04-04 | 2014-07-16 | 华侨大学 | 一种萘甲酰胺衍生物及其制备和应用 |
CN104447534A (zh) * | 2014-12-04 | 2015-03-25 | 厦门大学 | 6-[(7-氯喹啉-4-氧基)酚醚]-2-萘甲酰胺类衍生物及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN102603627B (zh) | 2013-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102812020B (zh) | 用于制备四唑甲磺酸盐的方法及其使用的新化合物 | |
CN102603627A (zh) | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物及其制备方法 | |
CN104507922A (zh) | 用于制备光学纯的并且任选地经取代的2-(1-羟基-烷基)-色烯-4-酮衍生物的新型方法以及其在制备药物中的用途 | |
JP2021517573A (ja) | 二つの4−{[(2s)−2−{4−[5−クロロ−2−(1h−1,2,3−トリアゾール−1−イル)フェニル]−5−メトキシ−2−オキソピリジン−1(2h)−イル}ブタノイル]アミノ}−2−フルオロベンズアミド誘導体の調製方法 | |
CN103288728A (zh) | 一种萘甲酰胺衍生物、其制备方法以及应用 | |
JP2016515101A (ja) | 新規スルホンアミドtrpa1受容体アンタゴニスト | |
WO2021008173A1 (zh) | 一种螺(3,3'-异丙基吡咯烷氧化吲哚)类肝x受体调节剂及其制备方法和应用 | |
CA2647990C (en) | New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | |
CN113336735B (zh) | 一种尿石素类化合物、制备方法、药物组合物及用途 | |
CN102260210B (zh) | 蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物的制备方法 | |
CN103351336A (zh) | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘甲酰胺衍生物及其制备方法 | |
JP2023538524A (ja) | スプライシングを調節する組成物 | |
Najahi et al. | Amino derivatives of indolone-N-oxide: Preparation and antiplasmodial properties | |
EP3353147B1 (en) | Synthesis of terphenyl compounds | |
CN106336378B (zh) | 一种喹啉-2-甲酸酯系列物的制备方法 | |
CN103896836A (zh) | N-苯基-6-[(7-氯喹啉-4-氧基)酚醚]-2-萘甲酰胺及其制备方法 | |
JPWO2004005276A1 (ja) | 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法 | |
CN107011322B (zh) | 一种脱氢苯基阿夕斯丁类化合物的制备纯化方法 | |
CN102329281B (zh) | 基于手性双环咪唑类亲核催化剂催化的c-酰基二氢唑酮及其制备方法 | |
CN103923004A (zh) | 一种萘甲酰胺衍生物及其制备和应用 | |
CN108558832A (zh) | 一种新型抗肿瘤药物奥希替尼衍生物及其制备方法 | |
JP7431155B2 (ja) | テトラヒドロナフチルウレア誘導体の製造方法 | |
CN106167465B (zh) | 一种依达拉奉二聚体杂质化合物及其制备方法 | |
WO2015012271A1 (ja) | 複素環化合物の製造方法 | |
CN103613548A (zh) | 富马酸尼唑苯酮的合成工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FUJIAN PACIFIC PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WANG LIQIANG Effective date: 20130326 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 150090 HARBIN, HEILONGJIANG PROVINCE TO: 362200 QUANZHOU, FUJIAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130326 Address after: 362200 Fujian Province Economic and Technological Development Zone Quanzhou Qingmeng Yatai Road Patentee after: Qiao Fengmin Address before: 150090, No. 251 Hongqi Street, Xiangfang District, Heilongjiang, Harbin (Wang Licheng, Municipal Intellectual Property Office) Patentee before: Wang Liqiang |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130206 Termination date: 20170531 |
|
CF01 | Termination of patent right due to non-payment of annual fee |